» Articles » PMID: 3289800

The Immune Response to the Cell Wall of Mycobacterium Bovis BCG

Overview
Date 1988 Mar 1
PMID 3289800
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Mice were immunized with the cell wall of BCG suspended in an oil-in-saline emulsion, and examined against time for the emergence of T cell-mediated acquired immunity. Evidence is presented that shows that levels of acquired resistance expressed in these animals over the first month following inoculation, and which enabled them to substantially resist an intravenous challenge infection with Mycobacterium tuberculosis, were completely nonspecific in nature, in that they were equally well expressed in normal and T cell-deficient mice, and were present at a time when no protective T cell activity could be passively transferred from the inoculated host. Paradoxically, in contrast, weak but statistically significant protective immunity could be detected in the spleens of CW-immunized mice approximately 3 months after inoculation, at a time when the donor animals were devoid of resistance to rechallenge. Finally, evidence is presented that shows that the CW material, if given subcutaneously, is highly immunogenic for the generation of delayed-type hypersensitivity effector T cells; however, these cells do not themselves contribute to protective immunity.

Citing Articles

The role of host soluble inflammatory mediators induced by the BCG vaccine for the initiation of in vitro monocyte apoptosis in healthy Brazilian volunteers.

Lima J, Siqueira M, Pedro T, Ponte C, Peres L, Marinho S J Inflamm (Lond). 2015; 12:60.

PMID: 26516315 PMC: 4625933. DOI: 10.1186/s12950-015-0105-0.


In vitro T-cell profile induced by BCG Moreau in healthy Brazilian volunteers.

Ponte C, Peres L, Marinho S, Lima J, Siqueira M, Pedro T Hum Vaccin Immunother. 2014; 11(2):450-7.

PMID: 25483636 PMC: 4514217. DOI: 10.4161/21645515.2014.970954.


Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans.

Nichols K, Bauman S, Schafer F, Murphy J Infect Immun. 2002; 70(2):591-600.

PMID: 11796587 PMC: 127722. DOI: 10.1128/IAI.70.2.591-600.2002.


Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene.

Johnson C, Cooper A, Frank A, Orme I Infect Immun. 1998; 66(4):1666-70.

PMID: 9529096 PMC: 108103. DOI: 10.1128/IAI.66.4.1666-1670.1998.


An essential role for endogenous interferon-gamma in the generation of protective T cells against Mycobacterium bovis BCG in mice.

Yang J, Mitsuyama M Immunology. 1997; 91(4):529-35.

PMID: 9378490 PMC: 1363871. DOI: 10.1046/j.1365-2567.1997.00288.x.


References
1.
Nakagawara A, Nathan C . A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells. J Immunol Methods. 1983; 56(2):261-8. DOI: 10.1016/0022-1759(83)90418-0. View

2.
Ribi E, Larson C, WICHT W, List R, Goode G . Effective nonliving vaccine against experimental tuberculosis in mice. J Bacteriol. 1966; 91(3):975-83. PMC: 315987. DOI: 10.1128/jb.91.3.975-983.1966. View

3.
Orme I, Collins F . Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. J Exp Med. 1983; 158(1):74-83. PMC: 2187069. DOI: 10.1084/jem.158.1.74. View

4.
Anacker R, Barclay W, Brehmer W, Larson C, Ribi E . Duration of immunity to tuberculosis in mice vaccinated intravenously with oil-treated cell walls of Mycobacterium bovis strain BCG. J Immunol. 1967; 98(6):1265-73. View

5.
Orme I . The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol. 1987; 138(1):293-8. View